DuPont de Nemours financials
$130.12−0.66%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 |
|---|---|---|---|---|---|---|---|
| Revenue | $6.85B | $6.72B | $6.61B | $13.02B | $12.57B | $11.13B | $15.44B |
| Gross profit | $2.36B | $2.22B | $2.17B | $4.62B | $4.59B | $4.07B | $5.41B |
| Gross margin | 34.5% | 33.0% | 32.8% | 35.5% | 36.6% | 36.5% | 35.0% |
| Operating income | $709.0M | $690.0M | $55.0M | $1.67B | $1.74B | -$1.39B | $312.0M |
| Net income | -$779.0M | $703.0M | $423.0M | $5.87B | $6.47B | -$2.95B | $497.0M |
| Net margin | −11.4% | 10.5% | 6.4% | 45.1% | 51.5% | −26.5% | 3.2% |
| Diluted EPS | $-5.58 | $5.04 | $2.82 | $35.25 | $35.67 | $-12.03 | $2.01 |
| EBITDA | $1.51B | $1.38B | $1.40B | $3.16B | $2.98B | $4.56B | $5.16B |
| Operating cash flow | $1.41B | $1.85B | $1.92B | $588.0M | $2.28B | $4.09B | $1.41B |
| Free cash flow | $1.08B | $1.56B | $1.62B | -$74.0M | $1.49B | $2.90B | -$1.06B |
| Diluted shares | 139.7M | 139.7M | 150.0M | 166.5M | 181.4M | 245.2M | 248.8M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $715.0M | $1.79B | $2.39B | $3.66B | $1.97B | $2.54B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $1.30B | $0.00 | — |
| Total debt | $3.19B | $7.17B | $7.80B | $8.07B | $10.78B | $15.61B |
| Total assets | $21.57B | $36.64B | $38.55B | $41.35B | $45.71B | $70.90B |
| Total liabilities | $7.47B | $12.84B | $13.83B | $14.34B | $18.66B | $31.83B |
| Shareholders' equity | $14.10B | $23.79B | $24.73B | $27.02B | $27.05B | $39.07B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology